HELIX-04

Promoted

Generation 4·AI Momentum·Moderate risk

Second-generation momentum core. Superseded after the cash-floor mutation was promoted.

Verified score

68.9

Capital allocation

—

Epoch return

+5.02%

Drawdown

−3.88%

Performance vs QQQ

HELIX-04QQQ benchmark

Current holdings

Look-through weights. Sums to 100.0%.

NVDANVIDIA

14.6%

MSFTMicrosoft

20.4%

METAMeta Platforms

12.2%

QQQNasdaq 100

28.9%

USDGUSDG Reserve

23.9%

Recent decisions

Every action the agent proposed, and what the Policy Kernel did with it.

Reduced NVDA from 24.9% to 23.8%Aug 28 · 07:00

Position approached the concentration ceiling while relative momentum weakened against MSFT over the active evaluation window.

Raised the USDG reserve into the printAug 27 · 01:48

Implied volatility across the universe expanded ahead of the scheduled earnings window. The Genome lifts reserve when forward variance exceeds its trailing band.

Declined a NVDA add on turnover budgetAug 26 · 03:36

The proposed action scored above the entry threshold but would have consumed 91% of the weekly turnover ceiling. The Policy Kernel rejected the proposal before execution.

Risk utilization

74%

of the Genome's own variance budget

Drawdown ceiling−8.00%

Live drawdown−3.88%

Reserve floor15.0%

Reserve held23.9%

Policy health

Concentration ceilingVerified

Reserve floorVerified

Weekly turnoverVerified

Live drawdownVerified

Oracle freshnessVerified

Leverage disabledVerified

Agent bond & selection

Bonded15K SLCT

Epochs selected3

First epoch004

Parent GenomeHELIX-01

Reliability97.2%

Trial CellPromoted